NCT07017894

Brief Summary

In this article, women were randomly assigned to the Breast Mask Containing Cabbage Leaves Extract group and Breast Mask without Cabbage Leaves Extract group, and the breast engorgement, pain, hardness, before and after each treatment were measured. At the end of the study breast mask user experience and continued breastfeeding were measured.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
154

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2025

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

June 4, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 12, 2025

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 13, 2026

Completed
Last Updated

June 12, 2025

Status Verified

June 1, 2025

Enrollment Period

1 month

First QC Date

June 4, 2025

Last Update Submit

June 4, 2025

Conditions

Keywords

breast engorgementpainhardness

Outcome Measures

Primary Outcomes (2)

  • Breast engorgement_self-rating scale

    Total four items of breast engorgement, pain, hardness, and heat. There are eleven grades, a score of 0 represents no problem at all, and a score of 10 represents the most severe degree.

    Day1, 2, 3

  • Breast hardness_Physiological measurements

    NEUTONE TDM-Z2 durometer pressure gauge

    Day1,2,3.

Secondary Outcomes (2)

  • Breast mask user experience

    Day 3

  • Continued breastfeeding

    Day 30

Study Arms (2)

breast mask containing cabbage leaves extract group

EXPERIMENTAL

Apply the breast mask containing cabbage leaf extract to the breasts, avoiding the nipples, for 20 minutes, 2 times a day, for 3 days.

Combination Product: Experimental: breast mask containing cabbage leaves extract group

breast mask without cabbage leaves extract group

SHAM COMPARATOR

Apply a breast mask without cabbage leaves extract to the breasts, avoiding the nipples, for 20 minutes, 2 times a day, for 3 days.

Combination Product: Sham Comparator

Interventions

apply breast mask to the breasts, avoiding the nipples, for 20 minutes, 2 times a day, for 3 days

breast mask containing cabbage leaves extract group
Sham ComparatorCOMBINATION_PRODUCT

Apply a breast mask without cabbage leaves extract to the breasts, avoiding the nipples, for 20 minutes, 2 times a day, for 3 days.

breast mask without cabbage leaves extract group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsyes
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years old.
  • Breastfeeding.
  • Physiological breast swelling, breast heaviness, lumps, milk plugging, breast pain after childbirth.
  • Able to read and understand Chinese.

You may not qualify if:

  • Stillbirth
  • Allergy to cabbage or sulfa.
  • lactation inhibitors agents used.
  • Fever symptoms (\> 38 degrees Celsius), including: wound infection, upper respiratory tract infection, urinary tract infection.
  • Breast symptoms, including: nipple cracks, skin damage, breast abscesses, mastitis, Malignant tumors.
  • Postpartum complications, including: postpartum hemorrhage, amniotic fluid embolism or other diseases requiring close care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Veterans General Hospital

Taipei, Beitou Dist, 112304, Taiwan

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Double-blind
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: two-group pre-test and repeated post-test study design
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2025

First Posted

June 12, 2025

Study Start

June 1, 2025

Primary Completion

July 1, 2025

Study Completion

April 13, 2026

Last Updated

June 12, 2025

Record last verified: 2025-06

Locations